The global autoimmune disease therapeutics market is anticipated to expand steadily from 2025 to 2035, driven by increasing cases of rheumatoid arthritis, psoriasis, and inflammatory bowel disease. The market is valued at USD 168.6 billion in 2025 and is forecast to reach USD 226.2 billion by 2035, reflecting a CAGR of 3.0%. The autoimmune disease …
Continue reading “Autoimmune Disease Therapeutics Market Grows to USD 226.2B at 3.0% CAGR”